- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03748004
IPS/Peer Support Intervention in the DTES
Optimizing the Employment Outcomes for People Living in the Downtown Eastside
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Skye Barbic, PhD
- Phone Number: 778 846 6134
- Email: skye.barbic@ubc.ca
Study Locations
-
-
British Columbia
-
Vancouver, British Columbia, Canada, V6A 1G9
- Recruiting
- Downtown Community Health Center
-
Contact:
- Smadar Levinson
-
Vancouver, British Columbia, Canada, V6A 3G3
- Recruiting
- Heatley Community Health Clinic
-
Contact:
- Smadar Levinson
- Phone Number: 6046199150
-
Vancouver, British Columbia, Canada, V6B 1R3
- Recruiting
- Pender Community Health Clinic
-
Contact:
- Smadar Levinson
- Phone Number: 6046199150
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adults, age 19 and over, accessing primary care services at the primary care centre listed in this study (CH Pender Community Health Centre)
- At least one visit to VCH Pender Community Health Centre
- Currently unemployed and not in school or post-secondary training.
- Able to provide informed consent and fluent in English (intervention is currently offered in English only).
- Not hospitalized at the time of recruitment.
Exclusion Criteria:
• Adults, age 19 and over who have access to mental health services
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Adults living in the DTES
36 out of the 72 recruited participants who live in the DTES will be randomly assigned to the intervention group (IPS & Peer Support). The IPS and Peer Support will actively work and support with each of the 36 participants in seeking employment and education for 16 weeks. IPS/SP will help participants identify their employment and educational goals, identify potential employers, help prepare their resumes and for interviews, and provide ongoing support during the 16 weeks. 36 out of the 72 participants who live in the DTES will be randomly assigned to the control group (WorkBC). Participants will be provided with WorkBC employment services. |
The 72 recruited clients receiving primary care services from one DTES clinical site who are employment ready will be randomly assigned to IPS and Peer Support (experimental group) or WorkBC control group
|
Placebo Comparator: Individuals 19 yrs or older settled in DTES
36 out of the 72 recruited participants who live in the DTES will be randomly assigned to the intervention group (IPS & Peer Support). The IPS and Peer Support will actively work and support with each of the 36 participants in seeking employment and education for 16 weeks. IPS/SP will help participants identify their employment and educational goals, identify potential employers, help prepare their resumes and for interviews, and provide ongoing support during the 16 weeks. 36 out of the 72 participants who live in the DTES will be randomly assigned to the control group (WorkBC). Participants will be provided with WorkBC employment services. |
36 out of the 72 participants who live in the DTES will be randomly assigned to the control group (WorkBC).
Participants will be provided with WorkBC employment services.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Securing employment
Time Frame: 18 months
|
RC will follow-up with all recruited clients who get employed through the IPS/Peer Support intervention and the WorkBC control group.
|
18 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
"PHQ-9" Questionnaire to measures level of depression
Time Frame: 18 months
|
Participants will answer the questions on this questionnaire using a likert scale.
A scoring system will calculate the final total number and we will assess mean change from the baseline.
The minimum score is 0/27 and the maximum score is 27
|
18 months
|
"GAD7" questionnaire to measure general anxiety disorder
Time Frame: 18 months
|
Participants will answer the questions on this questionnaire using a likert scale.
A scoring system will calculate the final total number and we will assess mean change from the baseline.
The minimum score is 0/21.
The maximum score is 21.
|
18 months
|
"C-PROM" questionnaire to measure Personal Recovery
Time Frame: 18 months
|
Participants will answer the questions on this questionnaire using a likert scale.
A scoring system will calculate the final total number and we will assess mean change from the baseline.
Minimum score is 0/120.
Maximum score is 120
|
18 months
|
"REQOL" questionnaire measures Recovery Quality of Life
Time Frame: 18 months
|
Participants will answer the questions on this questionnaire using a likert scale.
A scoring system will calculate the final total number and we will assess mean change from the baseline.
Minimum score is 0/64.
Maximum score 64.
|
18 months
|
"SWL" questionnaire measures satisfaction with life
Time Frame: 18 months
|
Participants will answer the questions on this questionnaire using a likert scale.
A scoring system will calculate the final total number and we will assess mean change from the baseline.
Minimum score is 5/35.
Maximum score is 35.
|
18 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Skye Barbic, PhD, University of British Columbia
Publications and helpful links
General Publications
- Sveinsdottir V, Lovvik C, Fyhn T, Monstad K, Ludvigsen K, Overland S, Reme SE. Protocol for the effect evaluation of Individual Placement and Support (IPS): a randomized controlled multicenter trial of IPS versus treatment as usual for patients with moderate to severe mental illness in Norway. BMC Psychiatry. 2014 Nov 18;14:307. doi: 10.1186/s12888-014-0307-7.
- Campbell K, Bond GR, Drake RE. Who benefits from supported employment: a meta-analytic study. Schizophr Bull. 2011 Mar;37(2):370-80. doi: 10.1093/schbul/sbp066. Epub 2009 Aug 6.
- Latimer E, Lecomte T. [Individual Placement Support (IPS) for people with severe mental disorders : An approach to favor in Quebec?]. Sante Ment Que. 2002;27(1):241-67. French.
- Bond GR, Drake RE. Making the case for IPS supported employment. Adm Policy Ment Health. 2014 Jan;41(1):69-73. doi: 10.1007/s10488-012-0444-6.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- H18-02740
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Substance Use
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)RecruitingSubstance Use | Substance Use Disorders | Cannabis Use | Alcohol Use, UnspecifiedUnited States
-
Icahn School of Medicine at Mount SinaiNational Institute on Drug Abuse (NIDA)RecruitingSubstance Use Disorder | Cocaine Use DisorderUnited States
-
Woebot HealthNational Institute on Drug Abuse (NIDA); Stanford UniversityCompletedSubstance Use Disorders | Alcohol Use Disorder (AUD)United States
-
Emory UniversityNational Institute on Drug Abuse (NIDA); Georgia Institute of Technology; CUNYCompletedSubstance-Related Disorders | Substance Abuse, Intravenous | Substance Use Disorders | Opioid Use | Substance Abuse | Opioid-use Disorder | Opioid Use Disorder, Severe | Substance WithdrawalUnited States
-
Woebot HealthStanford UniversityCompletedSubstance Use Disorders | Alcohol Use Disorder (AUD)United States
-
University of MichiganNational Institute on Alcohol Abuse and Alcoholism (NIAAA)RecruitingSubstance Use | Substance Use Disorders | Substance DependenceUnited States
-
Wake Forest University Health SciencesNational Institute on Drug Abuse (NIDA)RecruitingSubstance Use | Opioid Use | Drug Use | Substance MisuseUnited States
-
Centre for Addiction and Mental HealthUniversity of Missouri, St. LouisCompletedSubstance Use Disorders | Alcohol Use DisorderCanada
-
Istanbul UniversityCompletedSubstance Use | Substance Use Disorders | Substance AbuseTurkey
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)CompletedPTSD | Alcohol Use Disorders | Substance Use DisordersUnited States
Clinical Trials on IPS/SP
-
Mental Health Services in the Capital Region, DenmarkOdense University Hospital; Copenhagen Trial Unit, Center for Clinical Intervention... and other collaboratorsCompletedRecurrent Depressive Disorder | Bipolar Affective Disorder | Schizophrenia, Schizotypal and Delusional DisordersDenmark
-
Fraser HealthMinistry of Social Development and Poverty Reduction, British Columbia; Canadian...Completed
-
Mental Health Centre CopenhagenCompletedBipolar Disorder | Major Depressive Disorder | Anxiety Disorder | Affective DisorderDenmark
-
Beijing University of Chinese MedicineDongzhimen Hospital, BeijingNot yet recruitingChronic Heart FailureChina
-
VA Office of Research and DevelopmentCompletedSchizophrenia | Schizoaffective DisorderUnited States
-
Norwegian Institute of Public HealthUniversity of Tromso; Nordlandssykehuset HF; University of Melbourne; The University... and other collaboratorsUnknownSevere Mental DisorderNorway
-
Johns Hopkins UniversityTerminatedAtaxia-Telangiectasia (A-T)United States
-
Fotona d.o.o.UnknownStress Urinary IncontinenceCanada
-
L&C BioPROMeDisRecruitingHerniation, DiscKorea, Republic of
-
Allife Medical Science and Technology Co., Ltd.Beijing Hospital; The First People's Hospital of Yunnan Province/First People... and other collaboratorsUnknown